With the exception of sarcoma, melanoma and CD133 positive glioblastoma samples, ctag1b/a, is randomly re-activated in most samples examined and does not follow any pattern, that is, characteristic of stage or tumor type. This evidence concerns the gene PROM1 and neoplasm.